Travere Therapeutics (TVTX) earnings per share (EPS)

Earnings per share · fiscal 2025
-$0.29

Travere Therapeutics (TVTX) reported diluted earnings per share of -$0.29 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$4.08. Figures as of 17 Nov 2026, 22:36 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
-$0.29
Highest on record
$3.17fiscal 2015
Lowest on record
-$4.43fiscal 2014
Fiscal years on record
132013–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Travere Therapeutics earnings per share (EPS), in more detail

Across the 13 fiscal years on record (2013–2025), the highest was $3.17 in fiscal 2015 and the lowest -$4.43 in fiscal 2014.

History · 13 fiscal years

Earnings per share by fiscal year

Travere Therapeutics earnings per share (EPS), year by year

Travere Therapeutics (TVTX) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025-$0.29—
2024-$4.08—
2023-$1.50—
2022-$4.37—
2021-$3.01—
2020-$3.56—
2019-$3.46—
2018-$2.54—
2017-$1.54—
2016-$1.29 140.7% down
2015$3.17—
2014-$4.43—
2013-$2.44—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Travere Therapeutics and comparable companies
CompanyEarnings per shareFiscal year
MiniMed Group MMED-$1.302026
Adaptive Biotechnologies ADPT-$0.392025
Heartflow HTFL-$3.172025
CRISPR Therapeutics CRSP-$6.472025
Travere Therapeutics TVTX-$0.292025
Option Care Health OPCH$1.272025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TVTX

Travere Therapeutics, figure by figure

Travere Therapeutics (TVTX) overview: price, valuation and scorecardAll health care companies by market value

Travere Therapeutics earnings per share (EPS): questions and answers

What is Travere Therapeutics's diluted earnings per share?

Travere Therapeutics (TVTX) reported diluted earnings per share of -$0.29 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$4.08.

What are the highest and lowest diluted earnings per share figures on record for Travere Therapeutics?

Across the 13 fiscal years on record (2013–2025), the highest was $3.17 in fiscal 2015 and the lowest -$4.43 in fiscal 2014.

How is Travere Therapeutics's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Travere Therapeutics (TVTX) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/TVTX/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.